Prolacta Bioscience, which delivers breast milk to hospitals to feed premature babies, opens City of Industry processing facility.

Prolacta’s announcement also raised the possibility that the pharmaceutical development unit might eventually be spun off into a separate company, though no timetable was given.

DUARTE, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today the results of a ...

We’re joined by Dr. Melinda Elliott, neonatologist and chief medical officer at Prolacta Bioscience, to discuss what leading NICUs are doing today to nurture their tiniest patients.

Prolacta Bioscience, the world's leading hospital provider of 100% human milk-based nutritional products for critically ill and premature infants, announced today that Erin Hamilton Spence, MD ...

Prolacta Bioscience®, the pioneer in human milk-based neonatal nutritional products, announced today that the first patient has been enrolled in a clinical study to evaluate the effect of a ...

Dr. Melinda Elliott, a neonatologist and Chief Medical Officer at Prolacta Bioscience, joins us to discuss the importance of nutrition for premature infants.

Prolacta Bioscience ® is a global life sciences company dedicated to Advancing the Science of Human Milk ® to improve health outcomes for critically ill and premature infants.

More Than 50% of Level III & IV NICUs in U.S. Used Prolacta's 100% Human Milk-Based Products to Help Reduce Necrotizing Enterocolitis (NEC) in the Smallest Premature Infants in 2024 ...

Why everyone is suddenly so interested in US bond markets Mega Millions Winner Scores $112M Jackpot: Where Was Winning Ticket Sold? Yes, egg prices are up 60% — but these 10 things are actually ...

Prolacta Bioscience, the world's leading hospital provider of 100% human milk-based nutritional products for critically ill and premature infants, announced today that Erin Hamilton Spence, MD, IBCLC, ...